American Journal of Nutrition:食用乳制品有可能降低2型糖尿病风险

2021-07-28 MedSci原创 MedSci原创

基于38种已确认代谢物的评分与T2D风险呈负相关关系

流行病学研究发现乳制品消费与2型糖尿病(T2D)的风险之间存在适度的反向关联。与乳制品消费相关的血浆代谢物图谱是否反映了这种关系仍不清楚。

Jean-Philippe Drouin-Chartier团队在American Journal of Nutrition杂志发表文章,研究分析了与乳制品总消耗量和特定消耗量相关的血浆代谢物,并评价所确定的多代谢物谱与T2D之间的关系。

招募了1833名PREDIMED试验的参与者。验证性队列包括试验第1年的1522名预试参与者和4932名来自护士健康研究(NHS)、护士健康研究II(NHSII)和基于美国的卫生专业人员随访研究的参与者。使用验证的FFQS评估乳品消耗量。用LC-MS分析血浆代谢物(n=385)。用弹性网正则回归和10倍交叉验证程序确定了乳制品相关代谢物的分布。在发现和验证队列中评估了代谢物谱和T2D事件之间的联系。

与PREDIMED基线发现队列中确定的每个乳制品类别的消费相关的所有独特代谢物的回归系数图。

乳制品总摄入量与38种代谢物有关C14:0鞘磷脂(正系数)、 c34:0磷脂酰乙醇胺(正系数)和γ-丁基甜菜碱(负系数)与乳制品的总消耗量和特定消耗量呈正相关。在发现队列中,自我报告的乳制品总摄入量与相应的多代谢产物组合预测的乳制品总摄入量的皮尔逊相关系数为0.37(95%CI,0.33-0.40) ,在美国队列中为0.16(95% CI,0.13-0.19)。在调整了 T2D 风险因素后,乳制品摄入量相关的代谢物总分值越高,T2D风险越低[HR per 1 SD; 发现队列 0.76(95% CI,0.63-0.90) ; US验证队列: 0.88(95%CI,0.78-0.99)]。

综上所述,乳制品总摄入量与38种代谢产物有关,其中3种代谢产物与乳制品亚型(c14:0鞘磷脂、 c34:0磷脂酰乙醇胺、γ-丁基甜菜碱)一致。在西班牙和美国人群中,基于38种已确认代谢物的评分与T2D风险呈负相关关系。该研究为乳品潜在的生物标志物和乳品-T2D关系的机制提供了新的见解。然而,在反映乳制品摄入量的特异性方面,已确定的代谢物特征仍然不确定。

原文出处

Jean-Philippe Drouin-Chartier, Pablo Hernández-Alonso, Marta Guasch-Ferré, Miguel Ruiz-Canela, Jun Li, Clemens Wittenbecher, Cristina Razquin, Estefanía Toledo, Courtney Dennis, Dolores Corella, Ramon Estruch, Montserrat Fitó, A Heather Eliassen, Deirdre K Tobias, Alberto Ascherio, Lorelei A Mucci, Kathryn M Rexrode, Elizabeth W Karlson, Karen H Costenbader, Charles S Fuchs, Liming Liang, Clary B Clish, Miguel A Martínez-González, Jordi Salas-Salvadó, Frank B Hu, Dairy consumption, plasma metabolites, and risk of type 2 diabetes, The American Journal of Clinical Nutrition, Volume 114, Issue 1, July 2021, Pages 163–174, https://doi.org/10.1093/ajcn/nqab047

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1956337, encodeId=be1a195633e70, content=<a href='/topic/show?id=a74d1109c8' target=_blank style='color:#2F92EE;'>#2型糖尿病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1109, encryptionId=a74d1109c8, topicName=2型糖尿病风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 26 22:24:13 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661653, encodeId=0e7e166165348, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Nov 23 07:24:13 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043711, encodeId=4a311043e1114, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jul 28 17:24:13 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003343, encodeId=a3d110033431d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/2c53cab6aa5d4bd29a335e279262ba39/db40d4a3d1554f51a085a0a28530c46d.jpg, createdBy=93fa5558684, createdName=ms5000001769521388, createdTime=Wed Jul 28 15:34:16 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1956337, encodeId=be1a195633e70, content=<a href='/topic/show?id=a74d1109c8' target=_blank style='color:#2F92EE;'>#2型糖尿病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1109, encryptionId=a74d1109c8, topicName=2型糖尿病风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 26 22:24:13 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661653, encodeId=0e7e166165348, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Nov 23 07:24:13 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043711, encodeId=4a311043e1114, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jul 28 17:24:13 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003343, encodeId=a3d110033431d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/2c53cab6aa5d4bd29a335e279262ba39/db40d4a3d1554f51a085a0a28530c46d.jpg, createdBy=93fa5558684, createdName=ms5000001769521388, createdTime=Wed Jul 28 15:34:16 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1956337, encodeId=be1a195633e70, content=<a href='/topic/show?id=a74d1109c8' target=_blank style='color:#2F92EE;'>#2型糖尿病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1109, encryptionId=a74d1109c8, topicName=2型糖尿病风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 26 22:24:13 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661653, encodeId=0e7e166165348, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Nov 23 07:24:13 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043711, encodeId=4a311043e1114, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jul 28 17:24:13 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003343, encodeId=a3d110033431d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/2c53cab6aa5d4bd29a335e279262ba39/db40d4a3d1554f51a085a0a28530c46d.jpg, createdBy=93fa5558684, createdName=ms5000001769521388, createdTime=Wed Jul 28 15:34:16 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-07-28 misszhang

    谢谢MedSci提供最新的资讯

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1956337, encodeId=be1a195633e70, content=<a href='/topic/show?id=a74d1109c8' target=_blank style='color:#2F92EE;'>#2型糖尿病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1109, encryptionId=a74d1109c8, topicName=2型糖尿病风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 26 22:24:13 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661653, encodeId=0e7e166165348, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Nov 23 07:24:13 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043711, encodeId=4a311043e1114, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jul 28 17:24:13 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003343, encodeId=a3d110033431d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/2c53cab6aa5d4bd29a335e279262ba39/db40d4a3d1554f51a085a0a28530c46d.jpg, createdBy=93fa5558684, createdName=ms5000001769521388, createdTime=Wed Jul 28 15:34:16 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-07-28 ms5000001769521388

    学习了

    0

相关资讯

JCEM:不同血糖变异性的2型糖尿病患者糖化血红蛋白与全因死亡率的关联

在血糖变异性较高的患者中,HbA1c可能不是其全因死亡率的可靠指标。这些患者可能需要新的血糖控制指标来实现更好的糖尿病管理。

HBP:机器学习使用高阶功能连接可以区伴有或不伴有认知障碍的2型糖尿病与健康人群

跨大规模脑内网络的dFC存在鉴别同步性,可以将T2DM-CI(和T2DM-noCI)与HC区分开来。

J Periodontol:牙周清创后辅助使用ω-3和ASA有益于治疗2型糖尿病患者的牙周炎

补充ω-3多不饱和脂肪酸(ω-3 PUFA)和低剂量阿司匹林(ASA)已被提议作为控制慢性炎症性疾病的宿主调节方案。本研究旨在调查口服ω-3 PUFA和ASA作为牙

Diabetes Care:2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系

近日,糖尿病领域权威杂志Diabetes Care上发表了一篇研究文章,该研究使用来自韩国国家健康保险服务的数据旨在评估钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的使用与视网膜静脉阻塞(RVO)之间

Cardiovasc Diabetol:钠糖共转运体抑制剂可显著降低T2DM患者的心血管事件风险

启用SGLT-2i与T2DM患者较低的死亡率及心衰和CKD风险相关

JAHA:恩格列净对2型糖尿病患者心肌血流储备的影响

恩格列净并未改善伴有心血管高风险的2型糖尿病患者MFR。该研究并不支持用MFR的短期改善来解释结局试验中观察到的心血管事件减少情况。